Literature DB >> 6208711

Peritoneal lavage in severe acute pancreatitis.

A Lasson, G Balldin, S Genell, K Ohlsson.   

Abstract

An analysis is presented of 73 attacks of acute pancreatitis treated with non-operative peritoneal lavage, classified according to Ranson's 11 signs and followed up for on average four years. None of the 21 moderate attacks was associated with complications or mortality. In the 52 severe attacks, four patients (7.7%) died, new pseudocyst developed in five patients (9.6%) and abscess in four (7.7%), and diabetes was found in 12 patients (23%) at follow-up. In all these respects the severe attacks showed statistically significant difference from the moderate attacks, as did the need for assisted ventilation, the volume of gastric retention and the length of hospital stay. The authors conclude that non-operative peritoneal lavage is beneficial, probably by removing toxic substances from the peritoneal cavity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208711

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  4 in total

1.  Fibrinolytic enzymes in ascites during experimental acute pancreatitis in rats.

Authors:  Y Etoh; H Sumi; H Tsushima; M Maruyama; H Mihara
Journal:  Int J Pancreatol       Date:  1992-10

2.  Pancreatic surgery, not pancreatitis, is the primary cause of diabetes after acute fulminant pancreatitis.

Authors:  J Eriksson; M Doepel; E Widén; L Halme; A Ekstrand; L Groop; K Höckerstedt
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

3.  Effective peritoneal therapy of acute pancreatitis in the rat with glutaryl-trialanin-ethylamide: a novel inhibitor of pancreatic elastase.

Authors:  P Fric; J Slabý; E Kasafírek; P Kocna; J Marek
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

4.  Pancreatic resection versus peritoneal lavage in acute necrotizing pancreatitis. A prospective randomized trial.

Authors:  T Schröder; V Sainio; L Kivisaari; P Puolakkainen; E Kivilaakso; M Lempinen
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.